Literature DB >> 32433189

Important Interactions of Immunosuppressants With Experimental Therapies for Novel Coronavirus Disease (COVID-19): How to Act.

Tanja R Zijp1, Martha L Toren-Wielema1, Prashant V Nannan Panday1, Jos G W Kosterink1, Stefan P Berger2,3, Daan J Touw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32433189     DOI： 10.1097/FTD.0000000000000766

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  1 in total

Review 1.  Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week.

Authors:  Sonu Abraham; Anju Nohria; Tomas G Neilan; Aarti Asnani; Anu Mariam Saji; Jui Shah; Tara Lech; Jason Grossman; George M Abraham; Daniel P McQuillen; David T Martin; Paul E Sax; Sourbha S Dani; Sarju Ganatra
Journal:  J Am Coll Cardiol       Date:  2022-10-06       Impact factor: 27.203
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.